CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in ...

CHICAGO – A CRISPR-Cas9-based investigational therapy was ... was delivered to patients (n=36) with ATTR-CM, explained Marianna Fontana, MD, PhD, of University College London, and the mean ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Scientists and policymakers are meeting in Washington, DC December 1-3 to debate the use of CRISPR/Cas9, a tool that makes it possible to make changes to an organism's DNA almost as easily as ...

The CRISPR/Cas9 gene-editing technique has shown promise in fighting advanced colorectal cancer, according to results of the ...

In the study, researchers used CRISPR/Cas9 gene-editing to modify a type of immune cell called tumour-infiltrating ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes ... might be ...

The study applied a new approach that installed hairpin internal nuclear localization signal sequences (hiNLS) at selected sites within the backbone of CRISPR-Cas9. This approach contrasts with ...

The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs ...